| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.006 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.006 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.006 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.13 | 0.006 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.006 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.007 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.15 | 0.007 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.007 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.007 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |